The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics.
The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics.
复制标题
DOI:
10.1590/1516-4446-2021-1926
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Kloiber S
中科院分区:
文献类型:
--
作者:
Ahmed M;Boileau I;Le Foll B;Carvalho AF;Kloiber S
Social anxiety disorder (SAD) is a highly prevalent psychiatric disorder that presents with an early age of onset, chronic disease course, and increased risk of psychiatric comorbidity. Current treatment options for SAD are associated with low response rates, suboptimal efficacy, and possible risk of adverse effects. Investigation of new neurobiological mechanisms may aid in the identification of more specific therapeutic targets for the treatment of this disorder. Emerging evidence suggests that the endogenous cannabinoid system, also referred to as the endocannabinoid system (ECS), could play a potential role in the pathophysiology of SAD. This review discusses the known pathophysiological mechanisms of SAD, the potential role of the ECS in this disorder, current drugs targeting the ECS, and the potential of these novel compounds to enhance the therapeutic armamentarium for SAD. Further investigational efforts, specifically in human populations, are warranted to improve our knowledge of the ECS in SAD.
登录
查看更多内容
影响因子:
6.8
作者:
Bedse G;Bluett RJ;Patrick TA;Romness NK;Gaulden AD;Kingsley PJ;Plath N;Marnett LJ;Patel S
通讯作者:
Patel S
DOI:
10.1016/j.pnpbp.2012.10.024
发表时间:
2013-03-05
影响因子:
5.6
作者:
Almeida, Valeria;Levin, Raquel;Abilio, Vanessa C.
通讯作者:
Abilio, Vanessa C.
影响因子:
3.4
作者:
Campos, Alline Cristina;Soares, Vanessa de Paula;Guimaraes, Francisco Silveira
通讯作者:
Guimaraes, Francisco Silveira
影响因子:
8.2
作者:
Bar-Haim, Yair;Fox, Nathan A.;Ernst, Monique
通讯作者:
Ernst, Monique
影响因子:
7.3
作者:
Bisogno, T;Hanus, L;Di Marzo, V
通讯作者:
Di Marzo, V